Zimmer Biomet to Acquire Monogram Technologies in $177M Deal, Advancing Toward Fully Autonomous Orthopedic Robotics

Warsaw, IN and Austin, TX, July 14, 2025 (PRNewswire) -- Zimmer Biomet has entered into a definitive agreement to acquire Monogram Technologies for approximately $177 million in equity value, with an additional contingent value right of up to $12.37 per share based on future milestones. The acquisition will integrate Monogram’s AI-navigated and semi-autonomous knee arthroplasty robotics—cleared by the FDA in 2025—into Zimmer Biomet’s ROSA® platform, positioning the company as a frontrunner in fully autonomous orthopedic surgery. With this move, Zimmer Biomet aims to expand its robotics ecosystem and deliver unprecedented flexibility and innovation across the surgical continuum.

Read full article here.